Skip to main content

RA Patients on Biologics and tsDMARDs are still High Risk A new Swedish ARTIS registry study of key safety outcomes in

Apr 15, 2023 10:00 am
Social Author Name
Dr. John Cush
Tweet Content
RA Patients on Biologics and tsDMARDs are still High Risk A new Swedish ARTIS registry study of key safety outcomes in RA patients receiving either targeted synthetic or b/ts DMARDs, including JAKi, has been updated and affirms previously held risks. https://t.co/mqfP4deGJv https://t.co/m43GSRlrct
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×